Spiro-indoline-piperidine derivatives as selective GPR-40 activators for treating diabetes

• 收藏
• 分享

专利权人:

ELI LILLY AND COMPANY

发明人:

HAMDOUCHI, CHAFIQ,LINESWALA, JAYANA, PANKAJ

申请号：

NZ59897210

公开号：

NZ598972A

申请日:

2010.10.11

申请国别(地区):

NZ

年份:

2013

代理人:

摘要：

The disclosure relates to spiro-indoline-piperidine compounds of the formula (I), pharmaceutically acceptable salt thereof as well as a pharmaceutical composition, wherein the variables are as defined in the specification. These spiropiperidine compounds are selective GPR-40 activators and are suitable for treating diabetes.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/